Centre Leon Berard - Centre regional de lutte contre le cancer Rhone-Alpes

Lyon 69373

0 studies enrolling now · 3 studies all time

What they study most

HER2 Positive Breast Cancer, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Renal Cell Carcinoma

Studies at this site

• Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed
• A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL — Stopped early